![]()
展鹏
-
教授
博士生导师
硕士生导师
- 性别：男
- 毕业院校：山东大学
- 学历：博士研究生毕业
- 学位：医学博士学位
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2010-07-26
- 办公地点：山东大学国家大学生科技园（二环南路）3号楼14层1435房间
- 电子邮箱：zhanpeng1982@sdu.edu.cn
访问量：
-
[281]
刘新泳 , 展鹏 and 荆兰兰.
Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inh.
Drug Discovery Today,
24,
629,
2019.
-
[282]
展鹏 , 刘新泳 and 康东伟.
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors by exploring the structure.
Chemical Biology & Drug Design,
93,
430,
2019.
-
[283]
刘新泳 , 展鹏 and 鞠翰.
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Per.
Journal of Medicinal Chemistry,
60,
3533,
2017.
-
[284]
刘新泳 , 展鹏 and 周忠霞.
Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a.
Organic & Biomolecular Chemistry,
16,
1014,
2018.
-
[285]
展鹏 , 刘新泳 and 高萍.
1-Hydroxypyrido[2,3-d]pyrimidin-2(1H)-ones as novel selective HIV integrase inhibitors obtained via .
Bioorganic & medicinal chemistry,
25,
5779,
2017.
-
[286]
展鹏 , 刘新泳 and 黄伯世.
Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluati.
Expert Opinion on Therapeutic Patents,
27,
9,
2017.
-
[287]
刘新泳 , 展鹏 and 高萍.
Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV-1 RNase H inhibitors.
Chemical Biology & Drug Design,
93,
582,
2019.
-
[288]
刘新泳 , 展鹏 and 汪昭.
Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodru.
BIOORGANIC & MEDICINAL CHEMISTRY Journal,
27,
447,
2019.
-
[289]
刘新泳 , 展鹏 and 周忠霞.
Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidi.
Organic and Biomolecular Chemistry,
17,
3202,
2019.
-
[290]
展鹏 , 刘新泳 and 康东伟.
Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Tra.
《Journal of Medicinal Chemistry》,
62,
1484,
2019.
-
[291]
展鹏 , 刘新泳 and 黄伯世.
Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Bindi.
《Journal of Medicinal Chemistry》,
62,
2083,
2019.
-
[292]
展鹏 , 刘新泳 and 汪昭.
Design, synthesis, and antiviral evaluation of novel hydrazone-substituted thiophene[3,2-d]pyrimidin.
Chemical Biology & Drug Design,
92,
2009,
2018.
-
[293]
展鹏 , 刘新泳 and 张健.
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Vir.
Journal of Medicinal Chemistry,
61,
9976,
2018.
-
[294]
展鹏 , 刘新泳 and 鞠翰.
Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution.
Future Medicinal Chemistry,
11,
265,
2019.
-
[295]
刘新泳 and 展鹏.
Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candi.
《Journal of Medicinal Chemistry》,
62,
3251,
2019.
-
[296]
展鹏 , 刘新泳 and 黄伯世.
Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridi.
Bioorganic & medicinal chemistry,
25,
4397,
2017.
-
[297]
展鹏 , 刘新泳 and 孟青.
The development of an effective synthetic route of lesinurad (RDEA594).
Chemistry Central Journal,
11,
2017.
-
[298]
刘新泳 and 展鹏.
Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016).
Recent Patents on Anti-Cancer Drug Discovery,
12,
16,
2017.
-
[299]
展鹏 , 刘新泳 and 程锡强.
Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integr.
Expert Opinion on Therapeutic Patents,
27,
1277,
2017.
-
[300]
刘新泳 , 展鹏 and Zhang, Heng.
Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-bas.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
130,
209,
2017.
